However, the clinical development program was halted following serious adverse events, including a death that occurred during a clinical trial, although a definitive causal link with CJC-1295 was not established
The TGA reports a number of adverse events and other concerns received for unapproved peptide products, which include: severe allergic reactions, requiring doses of adrenaline and hospitalisation systemic inflammatory response syndrome (SIRS) (severe inflammation in the body), requiring hospital management generalised hypersensitivity symptoms such as fullbody intense itching, palpitations, pain and sweating wide ranging body side effects, including insomnia, blurred vision, extreme tiredness, flulike illness, joint pain and skin sensitivity musculoskeletal injuries, including plantar fasciitis and Achilles tendinitis, and poor product quality, including unsealed packaging from an online supplier
IGF-1 LR3 Storage & Handling IGF-1 LR3 Storage Reference State Lyophilized (powder) Storage -4F (-20C) freezer Duration Long-term storage, up to roughly 12 months
Unlike synthetic GH injections, peptide therapy works gradually and naturally, encouraging the body to self-regulate hormone production for long-term benefits